AnaptysBio GAAP EPS of $1.58 beats by $0.71, revenue of $108.25M beats by $21.16M
Source: SeekingAlpha
2026-03-03 16:27:32 ET
More on AnaptysBio
- AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Top Quant rated bullish small cap stocks among companies with high short interest
- Seeking Alpha’s Quant Rating on AnaptysBio
- Historical earnings data for AnaptysBio
- Financial information for AnaptysBio
Read the full article on Seeking Alpha
For further details see:
AnaptysBio GAAP EPS of $1.58 beats by $0.71, revenue of $108.25M beats by $21.16M
AnaptysBio Inc.
NASDAQ: ANAB
ANAB Trading
4.05% G/L:
$57.51 Last:
130,577 Volume:
$55.32 Open:
ANAB Latest News
ANAB Stock Data
$1,401,175,024
18,412,833
0.27%
71
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
